This post is part of a 12 articles feature on the best bets for investing in China. To see all the other recommendations in this special report, click here.

"Today, most independent drug stores in the U.S. have been replaced by the behemoth pharmacy departments; but in China, the business is still dominated by mom-and-pop operations." explains China stock expert Tony Sagami.

In his The Asia Stock Alert, he says, "But that is changing, and getting in on the ground floor with China Nepstar (NYSE: NPD) could make you a bundle of money."

This post is part of a special annual report -- Top Stock Picks '09 -- in which TheStockAdvisors.com asked 75 leading newsletter advisors to select their favorite investment for the new year.

"China Sky One Medical (NASDAQ: CSKI) -- which manufactures pharmaceutical, medicinal and diagnostic products -- is our top pick for 2009," says Benson George in The Growth Report.

"China Sky One has delivered solid results -- for the nine months ended September 30, 2008, revenues increased to $65.9 million, up 80% from $36.6 million in the year-ago period.

"Net income over this period was $21.9 million or $1.39 per diluted share, up from $11.2 million, or $0.90 per diluted share in the nine months ended September 30, 2007.

"Despite the economic downturn, China Sky continues to see strong demand and growth both organically and by way of acquisition.

"On Nov. 9, the company increased its 2008 revenue guidance by almost 10% to the $88 to $90 million range, representing more than an 80% increase from 2007.

"The company is highly profitable, and cash flow from operations added almost $27 million to its coffers for the first nine months of 2008.